Kol Jia Yong

Title: Kol Jia Yong: Innovator in Cancer Treatment

Introduction

Kol Jia Yong is a prominent inventor based in Singapore, known for his significant contributions to cancer treatment methodologies. His innovative work focuses on the Spalt-like transcription factor 4 (SALL4) and its implications in treating solid tumors. With a single patent to his name, Kol Jia Yong is making strides in the medical field.

Latest Patents

Kol Jia Yong holds a patent titled "Spalt-like transcription factor 4 (SALL4) and uses thereof." This patent describes methods for treating solid tumors that express SALL4 and Phosphatase and Tensin Homolog (PTEN). The methods involve administering an effective amount of a composition that inhibits SALL4 to individuals in need. Additionally, the invention outlines techniques for detecting aggressive cancer and assessing poor prognosis in cancer patients.

Career Highlights

Throughout his career, Kol Jia Yong has worked with esteemed institutions, including the National University of Singapore and Brigham and Women's Hospital. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Kol Jia Yong has collaborated with notable colleagues such as Li Chai and Todor Dimitrov, contributing to advancements in cancer treatment and research.

Conclusion

Kol Jia Yong's innovative work in cancer treatment through his patent on SALL4 showcases his dedication to improving patient outcomes. His contributions to the medical field are paving the way for future advancements in cancer therapies.